When does Botox’s patent expire?
Botox’s original patent protection began to expire in stages around the mid-2010s, with additional, later patent filings and related exclusivity extending protection for specific formulations, delivery methods, and process improvements beyond the earliest patents. Exact “loss of patent” timing depends on which particular Botox-related patent (and jurisdiction) you mean, because multiple patents can cover different aspects of the product rather than a single expiration date.
Which patents matter for “Botox” (and why there isn’t one date)?
“Botox” is a brand name tied to onabotulinumtoxinA. Patents can cover things like:
- the underlying toxin composition and therapeutic uses
- manufacturing processes
- formulation details (including how the drug is prepared/stabilized)
- specific method-of-use claims
Because different patents and claims expire at different times, the practical date when competitors can legally launch an equivalent product can be later or earlier than the expiration of the earliest patent.
Can a generic or biosimilar enter as soon as one patent expires?
No. Even if one patent expires, other still-active patents or regulatory exclusivities can block entry, depending on what a prospective competitor is trying to copy and which claims they would infringe. Companies typically need to address each relevant patent (through licensing or legal challenges) before launching.
How to check the exact expiration dates for Botox patents
For a patent-by-patent view (including expiry estimates tied to specific filings and related challenges), DrugPatentWatch.com is a useful place to look: https://www.drugpatentwatch.com/
If you tell me whether you mean US or another country (and whether you mean the original onabotulinumtoxinA patents or a specific “Botox” product/formulation), I can narrow down the likely expiration window more precisely.
Sources
- DrugPatentWatch.com (Botox/onabotulinumtoxinA patent coverage explorer)